MENU
+Compare
BFNH
Stock ticker: OTC
AS OF
Dec 12 closing price
Price
$0.90
Change
+$0.06 (+7.14%)
Capitalization
68.2M

BFNH BioForce Nanosciences Holdings, Inc. Forecast, Technical & Fundamental Analysis

BFNH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for BFNH with price predictions
Dec 18, 2024

BFNH's RSI Oscillator climbs out of oversold territory

The RSI Oscillator for BFNH moved out of oversold territory on December 12, 2024. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 36 similar instances when the indicator left oversold territory. In of the 36 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 18, 2024. You may want to consider a long position or call options on BFNH as a result. In of 103 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Moving Average Convergence Divergence Histogram (MACD) for BFNH turned negative on December 04, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 61 similar instances when the indicator turned negative. In of the 61 cases the stock turned lower in the days that followed. This puts the odds of success at .

BFNH moved below its 50-day moving average on December 04, 2024 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for BFNH crossed bearishly below the 50-day moving average on December 04, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 20 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BFNH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for BFNH entered a downward trend on November 27, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BFNH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (6.504). P/E Ratio (2.159) is within average values for comparable stocks, (26.887). BFNH's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.471). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (66.929).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BFNH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.

View a ticker or compare two or three
BFNH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Industry FoodSpecialtyCandy

Profile
Fundamentals
Details
Industry
N/A
Address
2020 General Booth Boulevard
Phone
+1 757 306-6090
Employees
3
Web
http://www.bioforceeclipse.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PIII0.20N/A
+1.80%
P3 Health Partners
REVB0.340.01
+1.75%
Revelation Biosciences
ARRY5.38-0.09
-1.65%
Array Technologies
CCK82.87-2.50
-2.93%
Crown Holdings
SMRT1.67-0.09
-5.11%
SmartRent

BFNH and Stocks

Correlation & Price change

A.I.dvisor tells us that BFNH and ASBFY have been poorly correlated (+11% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BFNH and ASBFY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BFNH
1D Price
Change %
BFNH100%
N/A
ASBFY - BFNH
11%
Poorly correlated
+1.86%
BSFC - BFNH
6%
Poorly correlated
-2.46%
BMBOY - BFNH
4%
Poorly correlated
-4.59%
BTTR - BFNH
3%
Poorly correlated
-6.22%
BABB - BFNH
2%
Poorly correlated
-1.50%
More